Detalhe da pesquisa
1.
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial.
J Clin Rheumatol
; 29(1): 16-22, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459119
2.
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.
Rheumatology (Oxford)
; 60(3): 1137-1147, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864685
3.
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
Leuk Lymphoma
; : 1-11, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712673
4.
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
Vasc Med
; 18(5): 263-74, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24052491
5.
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.
J Rheumatol
; 50(9): 1114-1120, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061234
6.
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.
Arthritis Rheumatol
; 73(5): 759-768, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205906
7.
A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
AIDS
; 32(7): 945-954, 2018 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29424776
8.
Reply.
Arthritis Rheumatol
; 73(9): 1771-1772, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750019
9.
Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
J Am Heart Assoc
; 4(8): e002034, 2015 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26296857